In this case, we observed a decreasing trend in the anti-SARS-CoV-2 spike antibody level (peak, 12,371 BAU/mL on day 32; positive, ≥0.8 BAU/mL), the vaccine-induced antibodies against the viral spike protein, measured using a quantitative Roche Elecsys® Anti-SARS-CoV-2 S assay (Fig. 1F ).
← all excerpts
Recovery from antibody-mediated biliary ductopenia and multiorgan inflammation after COVID-19 vaccination.
1
—
—